Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of allergy targets and biomarkers during allergen exposure in allergic rhinitis
2004-002872-41Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluticasone propionate in seasonal allergic rhinitis (SAR), sponsored by GSK. Primary endpoint: Target expression. Started Jul 2005; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2004-002872-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002872-41.